Stifel Financial
CSBR icon

Stifel Financial’s Champions Oncology CSBR Stock Holding History

Stifel Financial’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,942
Closed -$56.6K – 3382
2024
Q2 		$56.6K Sell
10,942
-250
-2% -$1.22K ﹤0.01% 3271
2024
Q1 		$54.8K Buy
+11,192
New +$65.5K ﹤0.01% 3252
2023
Q4 		– Sell
-10,442
Closed -$64.8K – 3344
2023
Q3 		$64.8K Sell
10,442
-7,636
-42% -$48.3K ﹤0.01% 3159
2023
Q2 		$115K Sell
18,078
-4,247
-19% -$21.9K ﹤0.01% 3154
2023
Q1 		$89.7K Buy
+22,325
New +$95.4K ﹤0.01% 3190

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Stifel Financial's CSBR Position: Q3 2024 in Review

Stifel Financial sold out of Champions Oncology (CSBR) in Q3 2024, closing a stake of 10,942 shares — an estimated $56.6K sold.

Stifel Financial first reported a position in CSBR in Q1 2023 and held it in 5 quarters. The position peaked at $115K in Q2 2023. 22 funds tracked by Wall St. Rank hold CSBR as of Q3 2024.

  • Stifel Financial reported no remaining Champions Oncology position as of Q3 2024 after selling out during the quarter.
  • Stifel Financial sold 10,942 Champions Oncology shares in Q3 2024, an estimated $56.6K.
  • Stifel Financial first reported a position in Champions Oncology in Q1 2023 and held it in 5 quarters.
  • Stifel Financial's Champions Oncology position peaked at $115K in Q2 2023.
  • 22 funds tracked by Wall St. Rank held Champions Oncology as of Q3 2024.

Based on Stifel Financial's 13F filing for Q3 2024, filed 14 Nov 2024.